HighTower Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Sell
11,129
-678
-6% -$15.4K ﹤0.01% 3266
2026
Q1
$253K Sell
11,807
-5,178
-30% -$108K ﹤0.01% 3305
2025
Q4
$363K Sell
16,985
-30,160
-64% -$618K ﹤0.01% 2881
2025
Q3
$790K Buy
+47,145
New +$707K ﹤0.01% 2275
2023
Q3
Sell
-10,128
Closed -$144K 3681
2023
Q2
$144K Buy
+10,128
New +$142K ﹤0.01% 2980
2022
Q1
Sell
-8,609
Closed -$233K 3564
2021
Q4
$233K Buy
8,609
+383
+5% +$10.3K ﹤0.01% 2645
2021
Q3
$234K Hold
8,226
﹤0.01% 2595
2021
Q2
$247K Sell
8,226
-33,146
-80% -$978K ﹤0.01% 2514
2021
Q1
$1.04M Sell
41,372
-49,262
-54% -$1.26M ﹤0.01% 1532
2020
Q4
$2.23M Sell
90,634
-7,736
-8% -$145K 0.01% 857
2020
Q3
$1.6M Buy
+98,370
New +$1.83M 0.01% 982
2020
Q1
Sell
-49,115
Closed -$1.37M 2395
2019
Q4
$1.37M Buy
+49,115
New +$1.23M 0.01% 990
2018
Q4
Sell
-4,598
Closed -$214K 2302
2018
Q3
$214K Buy
+4,598
New +$211K ﹤0.01% 1919
2017
Q2
Sell
-35,582
Closed -$2.46M 2281
2017
Q1
$2.46M Buy
35,582
+13,810
+63% +$959K 0.02% 691
2016
Q4
$1.45M Buy
21,772
+15,740
+261% +$1.02M 0.02% 817
2016
Q3
$401K Buy
+6,032
New +$413K ﹤0.01% 1336
2016
Q2
Sell
-4,255
Closed -$276K 1920
2016
Q1
$276K Sell
4,255
-1,007
-19% -$66.8K ﹤0.01% 1647
2015
Q4
$374K Sell
5,262
-43,339
-89% -$3.21M ﹤0.01% 1466
2015
Q3
$3.73M Sell
48,601
-1,085
-2% -$87.6K 0.05% 401
2015
Q2
$3.68M Buy
49,686
+4,004
+9% +$288K 0.06% 355
2015
Q1
$3.32M Sell
45,682
-1,835
-4% -$128K 0.05% 425
2014
Q4
$3.14M Buy
47,517
+4,715
+11% +$288K 0.05% 430
2014
Q3
$2.35M Buy
42,802
+2,776
+7% +$157K 0.04% 498
2014
Q2
$2.33M Buy
40,026
+1,750
+5% +$103K 0.04% 520
2014
Q1
$2.37M Buy
38,276
+2,896
+8% +$168K 0.05% 460
2013
Q4
$1.89M Buy
35,380
+2,900
+9% +$156K 0.04% 485
2013
Q3
$1.62M Buy
32,480
+2,358
+8% +$115K 0.04% 470
2013
Q2
$1.38M Buy
+30,122
New +$1.35M 0.04% 497

Other funds holding MD

HighTower Advisors's MD Position: Q2 2026 in Review

HighTower Advisors reduced its Pediatrix Medical (MD) stake by 5.7% in Q2 2026, selling an estimated $15.4K and leaving 11,129 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #3266.

HighTower Advisors first reported a position in MD in Q2 2013 and has held it in 28 quarters since. The position peaked at $3.73M in Q3 2015. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • HighTower Advisors held 11,129 shares of Pediatrix Medical worth $282K as of Q2 2026.
  • HighTower Advisors sold 678 Pediatrix Medical shares in Q2 2026, an estimated $15.4K.
  • Pediatrix Medical made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3266 holding.
  • HighTower Advisors first reported a position in Pediatrix Medical in Q2 2013 and has held it in 28 quarters since.
  • HighTower Advisors's Pediatrix Medical position peaked at $3.73M in Q3 2015.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.